Figure 1From: Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-β1 and stem cell factor in plasma of patients with nasopharyngeal carcinomaBox and whisker plot representing EBV DNA load in 34 NPC patients who experienced significant decrease in plasma viral DNA load following treatment (t(33) = 2.566, p < 0.05). Pre-treatment EBV DNA load is 1669 ± 637 copies/mL (median = 243 copies/mL) as compared to 57 ± 37 copies/mL post-treatment (median = 0 copies/mL).Back to article page